Pharma 2.0 Series Kick-off - Rx for the Future
Details
We are very pleased to announce the kick off for the Pharma 2.0 Series, Rx for the Future. At Pharma 2.0 events we will examine a few companies that are trying to change the way the pharmaceutical industry works and go deep on topics in the space.
We also would like to express our appreciation to the incubator Blueprint Health (http://www.blueprinthealth.org) for supplying a venue. This is our first event there and we are very pleased to be able to introduce this great space to the community.
Thank you as well to Truveris (http://www.truveris.com), our new sponsor for the series enabling us to provide upgraded refreshments. Thank you!
And now, a word from our Sponsor:
____________________________________________________
Truveris, Maker of TruBid, a genius idea that works for employers, and is definitely the Rx of the Future.
Truveris' TruBid technology revolutionizes the pharmacy RFP process. TruBid is the only platform capable of an automated analysis with instantaneous financial and qualitative results. It can be implemented directly or with the help of your consultant or broker. For more info, Click Here (http://www.truveris.com/products/?product=trubid). (I highly recommend the video.)
_____________________________________________________
Also Sponsored by Wellness Layers! Thank you Lucy, Olga, Amir, and the gang for your support and membership for over 3 years!
_____________________________________________________
http://photos3.meetupstatic.com/photos/event/d/4/5/0/event_160494352.jpeg
Wellness Layers builds robust web and mobile portals and ecosystems for leading companies in the health and wellness industry to meaningfully engage members and patients.
________________________________________________________________
Agenda:
5:45 - Meet Tweet, and Greet (Hashtag #MedStartr) Happy Hour sponsored by Truveris
6:05 - 6:15 - Panel Introductions
6:20 - 7:30 - Five Minute Presentations, Five minute Q & A led by Panel
7:30 - 7:45 - Break
7:45 - 8:15 - Panel Discussion - The Future of Pharma
8:15 - 8:45 - Networking Time
8:45 - Whenever - After Event - Location TBD (recommendations welcome)
Our Presenters
http://photos1.meetupstatic.com/photos/event/b/9/9/8/event_156287512.jpegA.J. Loiacono, EVP of Sales and Marketing, Truveris (http://www.truveris.com) - Truveris provides the technology to control the full lifecycle of your pharmacy benefits plan and represents the first fully automated platform to manage bidding, contracting, and invoice reviews in real-time.
With TruBid (http://www.truveris.com/products/), your RFP is managed in under 30 days and delivers the best benefit plan at the lowest price point. With TruGuard (http://www.truveris.com/products/), you receive the oversight to enforce your contract and ensure your costs are accurate.
Truveris provides cost savings and ensures plan integrity. Our products can be implemented directly or through your existing consultant or broker.
A.J. Loiacono - Prior to co-founding Truveris, Loiacono was a SVP and Partner with SMS, a software development firm specializing in software-as-a-service (SaaS). Loiacono also served as the President of Victrix LLC, an information technology company providing support and implementation services for enterprise resource planning (ERP) systems. Loiacono led Victrix to record growth over five years and successfully negotiated the sale of the firm. In addition to his involvement with Victrix, Loiacono has a decade of financial industry experience having served as the Managing Director of Artemis Venture Capital and as a Senior Account Executive with Fidelity Investments. Loiacono is a graduate of Manhattanville College where he earned a B.A. in Finance.
Ezra Hanz, VP Business Development, Dx-Script (http://www.dx-web.com/dxscript/information.html), an ePrescribing application with over 18,000 providers using it and an average 3.5 million new scripts written monthly at little or no cost to the provider and with a patented patient education module that works for patients, Doctors, and our Pharmaceutical clients.
Nita Nehru and Venkat Gullapalli, Co-Founders - Medikly (http://www.medikly.com) - White-label engagement platforms to listen to, understand, and engage physicians. Venkat Gullapalli, co-founder and CEO, is a pediatrician with an 11-year background in pharmaceutical marketing and medical education and Nita Nehru, co-founder and VP of Business Development & Channel Partnerships is a serial entrepreneur with 7 years of experience in business development and relationship management for SaaS companies.
Murray Jones, CEO TalkAboutHealth (http://www.talkabouthealth.com) - TalkAboutHealth helps pharmaceutical marketing become more targeted, interactive, and effective. We reach and engage patients based on disease, treatment, stage, and more, providing branded interactive campaigns via Q&A workshops, videos, email marketing, featured content, and social media that both raises awareness and educates. TalkAboutHealth is a patient engagement platform that provides access to the world's leading medical professionals who share their knowledge and expertise, which we then organize and curate into a library of valuable health information.
Cliff Jones, Co-Founder, Allazo Health (http://www.allazohealth.com) - Allazo is an analytics firm that solves the problem of medication non-adherence. Its AllazoEngine leverages existing member data both to predict medication non-adherence and to recommend the most effective intervention strategy for each individual. Clifford Jones: Prior to starting Allazo, Cliff worked at CVS Caremark where he designed and built their latest generation medication adherence program, which won several industry awards.
Josh Stein, Co-Founder, AdhereTech (http://www.adheretech.com/) - AdhereTech's Patented Smart Bottle Technology measures the exact contents of the bottle at regular intervals and wirelessly uploads the data to their server. Friendly reminders are sent to patients who missed a dose, thereby increasing adherence.
The Moderator
http://photos2.meetupstatic.com/photos/event/b/8/e/4/event_156287332.jpegDR. JIM GOLDEN is a Partner at Accenture. He works within the Accenture Analytics and Marketing Services growth platform leading the Global Life Science Analytics Practice and supporting the Global Healthcare Data Analytics Group. His work focuses on the development of data analytics strategy, platforms, offerings and solutions for Accenture’s pharmaceutical, payer, provider and government clients. His most recent work focuses on the areas of Comparative Effectiveness Research (CER) and realizing the utility of real-world clinical evidence for driving drug discovery and commercialization. Dr. Golden is also an angel investor focused on biotechnology and healthcare IT startup companies in New York and Boston.
Our Panelists
New Panelist!
http://photos4.meetupstatic.com/photos/event/e/0/1/2/event_158337362.jpegCarlos Martin, Senior Global Brand Director in Novartis Oncology
Carlos started his career in Frito Lay (Spain) in 1996 after graduating as Economist from ESADE in Barcelona. After completing studies at the Thunderbird Global School of Management as a Fulbright Scholar in 2002, Carlos joined the USA LifeSciences industry working in Specialty Sales & Marketing for Schering Plough – Merck. He joined the Cardiovascular & Metabolism Franchise in Novartis Pharma in 2005 in Switzerland in, taking roles of increasing responsibility in Marketing & Sales management in strategy and operations having launched 6 products in US, Europe and Globally.
http://photos2.meetupstatic.com/photos/event/4/9/f/4/event_154218932.jpeg
Adel Laoui, PhD, MBA
Program Leader Bi-lateral Partnership Initiatives
European American Chamber of Commerce of New Jersey (EACCNJ) (http://www.eaccnj.org)
LinkedIn: http://www.linkedin.com/in/adellaoui
Dr. Laoui is an international senior executive with expertise in pharmaceuticals discovery and development, and healthcare technologies and services. Ph.D and MBA in finance, marketing and business strategy with 20 years of experience across the EU, US and ASIA. Most recently he served as Sanofi's, Director of Healthcare Solutions.
Dr. Laoui has been instrumental in innovation of two anti-cancer blockbuster drugs, Taxotere and Eloxatin that were developed and marketed. Dr Laoui has been one of the top leaders to drive the new Sanofi R&D, transforming towards a more diversified healthcare company, and for the genesis of an entrepreneurial Aging business unit focusing on developing new innovative integrated and personalized healthcare solutions that bundle drug or functional-medical food with devices and services.
Dr. Laoui is highly skilled in advanced analytics and developed an integrated data platform (genomics, biology, chemistry, clinic and personal health record) that enable effective systems biology and translational approaches that catalyze evidence-based medicine. Lastly Dr. Laoui was an early adaptor of web analytics technology leading to improved customer’s segmentation and targeted marketing that drove multi-channel marketing strategy for the Aging population segments.
http://photos4.meetupstatic.com/photos/event/5/8/2/2/event_156082562.jpegAli Ardati, Ph.D - Senior Manager in Pharmaceuticals, Former Sanofi - Head of Quality of Life, Pain and Urology, Therapeutic Scientific Unit-Aging, http://www.linkedin.com/in/aliardati )
Dr. Ardati has 17 years research and drug discovery experience in a pharmaceutical setting, from Roche to Aventis to Sanofi, 3 of the top 5 pharmaceuticals. He received his PhD from the University of Montreal in Molecular Biology. Dr Ardati is highly talented in integrating information from different disciplines, including genomics, biochemistry, molecular biology, in vitro and in-vivo pharmacology that led to initiating new discovery projects and progressing projects through various stages of pre-clinical development. Dr. Ardati has an extensive experience in pain and urology, autoimmune disease/immunology (asthma, COPD, rheumatoid arthritis, IBD/IBS), cardiovascular and CNS diseases. For the last 3 years, he developed a great knowledge of the Aging biology in particular identifying emerging underlying conditions affecting the elderly population as they live longer. He has been instrumental at defining and implementing strategies, establishing a diversified projects portfolio of small molecule, biologic and devices. Dr Ardati is well published in top tier peer reviewed journals, holds several issued patents and was an invited speaker at an international pain conference in London 2011.
http://photos2.meetupstatic.com/photos/event/b/1/0/0/event_156285312.jpegTalya Miron-Shatz, PhD, is a psychologist, who focuses on patient comprehension and motivation, as well as on their implications to adherence and outcomes. She is an accomplished scientist who over worked with Nobel Laureate Daniel Kahneman at Princeton University, taught consumer behavior at Wharton, published in peer reviewed journals and books. Talya is co-founder and CEO of CureMyWay, a start-up company that promotes behavioral change towards better health. Her commitment to bridging industry and decision science led her to chairing the startup panel at the Medicine 2.0 conference, and to speaking at multiple industry events. She brings her unique insights on consumer and prescriber behavior and barriers to her work with big pharma: Johnson & Johnson, Pfizer, Novartis, BMS, and other health and media companies.
http://photos2.meetupstatic.com/photos/event/b/0/7/4/event_156285172.jpeg
Rami A. Rafeh, Pfizer. Rami is part of the Worldwide Business Development & Innovation group for Pfizer Inc. based out of headquarters in NYC, reporting to the head of innovation. Prior to his appointment, Rami managed a global Drug Safety team in Worldwide Safety and Regulatory Operations responsible for activity within pharmacovigilance and adverse event reporting. Rami joined Pfizer in early 2006 and has since collaborated with various therapeutic areas and cross functional groups including Medical Information, Product Quality Complaints, Safety Strategy, Regulatory Operations, Operational Excellence, Business Technology, Quality and Legal.
After receiving a Bachelor’s degree from Binghamton University in Biology, Rami obtained a Master’s degree in Biomedical Sciences with a concentration in Stem Cells from the University of Medicine & Dentistry of NJ, where he was an IRB member. Rami also has a Master’s degree in Health Policy and Management from Columbia University, where he completed a concentration in a joint program through the department of Bioinformatics and Weill Cornell Graduate School of Medical Sciences in Health Information Technology, focusing as a Health Information Management and Exchange specialist.
Should be a great show! We hope you can make it. Thank You for your support!
Warm Regards,
Alex Fair
Organizer, Health 2.0 NYC, (http://www.health20nyc.com) the world's largest healthcare innovation meetup group
MedStartr.com (http://www.medstartr.com), Helping great new healthcare ideas get found and funded faster
FairCareMD.com, (http://www.faircaremd.com) Price Transparency and Appointment Scheduling. Now for Any Doctor in America for Free!
Functional Solutions to Enable the Healthcare Revolution
portal ecosystems and mobile applications for clients in the health and wellness industry
